| 000 | 01072 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250514191633.0 | ||
| 264 | 0 | _c20040610 | |
| 008 | 200406s 0 0 eng d | ||
| 022 | _a1538-3598 | ||
| 024 | 7 |
_a10.1001/jama.291.22.2701-b _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRuiz-Irastorza, Guillermo | |
| 245 | 0 | 0 |
_aAntiphospholipid antibodies and risk for recurrent vascular events. _h[electronic resource] |
| 260 |
_bJAMA _cJun 2004 |
||
| 300 |
_a2701; author reply 2702-3 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAntibodies, Anticardiolipin _xblood |
| 650 | 0 | 4 |
_aAntibodies, Antiphospholipid _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInternational Normalized Ratio |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aStroke _xepidemiology |
| 650 | 0 | 4 |
_aThrombosis _xepidemiology |
| 700 | 1 | _aKhamashta, Munther A | |
| 700 | 1 | _aHughes, Graham R V | |
| 773 | 0 |
_tJAMA _gvol. 291 _gno. 22 _gp. 2701; author reply 2702-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/jama.291.22.2701-b _zAvailable from publisher's website |
| 999 |
_c14894132 _d14894132 |
||